Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Exercise/Conversion of 5,305 MIRM shares, $101.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 5,305 | $101.8K |
| Sep 3, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 30,000 | $88.1K |
| Aug 11, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 20,000 | $58.7K |
| Jul 17, 2026 | Arcutis Biotherapeutics, Inc. (ARQT) | Grant/Award | 4,315 | n/a |
| Jul 8, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 20,000 | $58.7K |
| Jun 2, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 30,000 | $88.1K |
| Mar 17, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 25,000 | n/a |
| Feb 4, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Sale | 9,108 | $940.9K |
| Jan 30, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Grant/Award | 67,000 | n/a |
| Jan 27, 2026 | Mirum Pharmaceuticals, Inc. (MIRM) | Exercise/Conversion | 12,500 | n/a |